Jan-Bart M. Koorstra

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer

Georg Feldmann, Volker Fendrich, Karen McGovern et al. · Molecular Cancer Therapeutics · 2008 · 275 citations · Full text

Medicine, Oncology, Pharmacology +17

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

Jan-Bart M. Koorstra, Collins Karikari, Georg Feldmann et al. · Cancer Biology & Therapy · 2009 · 204 citations · Full text

Medicine, Cancer Biology, Oncology +17

<i>In vivo</i>characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

Savita Bisht, Georg Feldmann, Jan-Bart M. Koorstra et al. · Molecular Cancer Therapeutics · 2008 · 66 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia

Jan-Bart M. Koorstra, Seung‐Mo Hong, Chanjuan Shi et al. · Modern Pathology · 2009 · 40 citations · Full text

Medicine, Oncology, Pathology +16

Undifferentiated Carcinoma With Osteoclastic Giant Cells (UCOCGC) of the Pancreas Associated With the Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM)

Jan-Bart M. Koorstra, Anirban Maitra, Folkert H.M. Morsink et al. · The American Journal of Surgical Pathology · 2008 · 25 citations · Full text

Medicine, Genetics, Oncology +17